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Earlier studies from this and other laboratories demonstrated that certain naturally 
occurring steroid metabolites, formerly considered to be physiologically inactive end 
products of hormone metabolism, strongly stimulate porphyrin and &aminolevulinic 
acid synthase (ALA-S) 1 formation in cultured chick embryo liver eeUs (1, 2) as well as 
in vivo in the liver of the chick embryo (3).  Steroid metabolites with a  5fl-structure 
(A:B  cis)  were  more  potent  in  this  respect  than  their  5a-epimers  or  their  parent 
compounds. 5fl-steroids which induce porphyrin synthesis in chick embryo liver cells 
have also been shown to induce the early synthesis of hemoglobin in the erythroblasts 
of the chick blastoderm (4) and a 5fl-steroid receptor in this primitive avian tissue has 
been identified (5). 
These steroid metabolites  have been also  reported to stimulate erythropoiesis in 
vivo in mice. For example, Gorshein and Gardner  (6)  described enhanced erythro- 
poiesis in exhypoxic polycythemic mice after 5fl-steroid administration as determined 
by 59Fe incorporation into peripheral erythrocytes. Gordon et al. (7) reported similar 
results using both normal and  poiycythemic mice;  in addition, their study showed 
that an antibody preparation against erythropoietin abolished the effects of testoster- 
one, but not those of 5fl-steroids. These data thus suggested that 5fl-steroids can have 
effects on erythropoiesis that are independent of the action of erythropoietin. Besa et 
al. (8) later demonstrated that the 5fl-compound, etiocholanolone (5fl-androstan-3a- 
ol-17-one),  increased  erythrocyte mass  in  squirrel  monkeys,  confirming  that  such 
steroid metabolites may stimulate erythropoiesis not only in the erythroid tissues of 
birds, rodents, but also in vivo in primates. 5fl-steroids have also been demonstrated 
to increase both heme and  globin synthesis  in suspension  cultures of human  bone 
marrow cells (9,  10). 
The development of newer methodology for the study of hematopoietic stem cells 
in culture (11-13) made it possible to examine the mechanism and site of action of 
erythropoietin and  steroids  on  the  development of erythroid colonies  in  semisolid 
media  (14).  Using  rat  bone  marrow  cells,  Singer et  al.  (15)  reported  that  certain 
steroids enhanced erythroid colony growth in vitro and suggested that etiocholanolone, 
a prototype 5fl-steroid, may act on early erythroid progenitor cells (16). The clinical 
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usefulness  of this  specific  metabolite  in  the  therapy  of patients  with  severe  bone 
marrow failure has been suggested by the studies of Besa et al. (17). 
The present study was undertaken  to examine the influence of steroid metabolite 
pairs which are epimeric at the C5 position on the development of erythroid colonies 
derived from  human  bone marrow  using an  in vitro semisolid culture method  (12). 
This technique permits an evaluation of the effects of chemicals on erythroid colony 
growth; such growth is dependent on cellular proliferative activity. The data obtained 
show  that  steroid  metabolites enhance  the  in  vitro  growth  of both  early primitive 
erythroid progenitors, i.e. burst-forming units-erythroid (BFU-E), and later erythroid 
progenitors,  i.e.  colony-forming  units-erythroid  (CFU-E)  of  normal  human  bone 
marrow;  they indicate that  5fl-compounds are generally more potent  in this growth 
promoting effect  than  their 5a-epimers;  and  they demonstrate  a  steroid effect on  a 
very early stage of erythroid differentiation. 
Materials  and  Methods 
Steroid Metabolites.  Steroids were either purchased  from  Sigma Chemical Co.  (St.  Louis, 
Mo.) or prepared by standard synthetic methods from appropriate steroid precursors by Dr. H. 
L.  Bradlow,  Laboratory  of Steroid  Biochemistry,  The  Rockefeller  University,  N.  Y.  All 
compounds were purified by recrystallization from appropriate solvent mixtures. The purity of 
each compound was rigorously established by comparison with standards of known purity using 
two or more thin-layer chromatographic systems. No compound was utilized in these studies 
which was  not  shown  to be homogeneous.  Steroids were dissolved in  propylene glycol and 
added to the bone marrow culture at a concentration of 10  -7 M, which has been shown to be 
optimal for erythroid colony formation (15).  C5 epimerie pairs of steroids were studied in all 
experiments. 
Erythroid Colony Assay.  Erythroid progenitors (BFU-E and CFU-E) were assayed using the 
in  vitro culture technique which was originally described by Iscove et  ai.  (12)  with  minor 
modifications. Briefly, aliquots of bone marrow specimens aspirated from iliac crests of healthy 
adults  at  the  Memorial Sloan-Kettering Bone  Marrow  Donor  Center  were  provided to  us 
through the courtesy of Dr. M. J. Murphy, Jr. Diluted marrow cells (1:2 to  1:5) in a-medium 
(Flow Laboratories, Inc.  Rockville, Md.) were applied to a  6.4%  Ficoll 400  (Pharmacia Fine 
Chemicals, Div. of Pharmacia Inc., Piscataway, N. J.), 9.8% sodium metrizoate (Nygaard Co., 
Accurate Chemical & Scientific Corp., Hicksville, N. Y.) solution as described previously (18), 
and interface fractions were collected. Mononucleated cells which had been harvested from the 
interface were treated with NH4CI:Tris HCI (pH  7.4):  KHCO~ solution (19) to iyse contami- 
nating erythrocytes. 2  ×  10  s nucleated cells were resuspended in 1 ml of a-medium containing 
0.8% methyleelluiose (The Dow Chemical Co., Midland, Mich.), 30% fetal bovine serum (Flow 
Laboratories, Inc.,  Rockville, Md.),  1%  bovine serum albumin  (Calbiochem-Behring Corp., 
American Hoeset Corp., San Diego, Calif.), and 0.1, 0.25 or 0.5 IU of Step III sheep plasma 
erythropoietin (Connaught  Laboratories, Ontario, Canada) and the cells were placed in a  35 
×  10 mm plastic Petri dish (Lux Scientific Corp., Newbury Park, Calif.). The cell suspensions 
were incubated at  37°C  in  5%  CO2  in  air with saturated humidity. The  number of red to 
reddish erythroid colonies containing >8 cells (CFU-E) was counted after 7 d  of incubation, 
and the number of erythroid bursts having macroscopic dimensions of clusters of erythroblasts 
(BFU-E) was enumerated on day 14, using an inverted microscope without staining, as reported 
previously (20, 21). 
Assay of BFU-E and CFU-E.  Three sets of experiments were conducted.  In  the first, the 
influence of the continued presence of steroids on the development of BFU-E and CFU-E was 
examined  in  the presence of erythropoietin. Each  steroid was  added  to cultures of normal 
at a  10- -M concentration and the cultures were incubated in the  human bone marrow cells  7 
presence of 0.1  IU of erythropoietin. The numbers of CFU-E and  BFU-E were counted on 
appropriate  days  as  indicated  above.  Uroporphyrinogen-I synthase  (URO-S)  activity was 
determined as described earlier (22)  in the cells which were harvested from duplicate plates 
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Secondly, the effect of preincubation with steroids, followed by incubation with erythropoi- 
etin, on the development of BFU-E and CFU-E was examined. Cells were preincuhated with 
10  -v M of each steroid solution in a-medium containing 40% fetal calf serum and  10% bovine 
serum albumin for 48 h at 37°C in 5% CO2-95% air. After a 48-h incubation, cells were washed 
with modified Ham's F 12 medium (19) three times, and then resuspended in semi-solid medium 
containing methylcellulose in the presence of 0.5 IU of erythropoietin. BFU-E and CFU-E were 
counted on day 14 and day 7 of incubation, respectively. 
The purpose of the third experiment was to evaluate the effect of delayed addition of steroids 
on the formation of erythroid colonies. Marrow cells were incubated in the semi-solid medium 
in the presence of 0.25  IU of erythropoietin, and either 5a- or 5/3-androstane-3a, 1 l/~-diol-17- 
one was added to culture dishes on day 0, day 2, or day 4 at a  10-7-M final concentration. 
These metabolites are derived from the adrenal hormone 11/~-hydroxyandrostenedione. Neither 
the 5or- nor the 5]~-metabolite  of this adrenal hormone has androgenic properties. The numbers 
of BFU-E and CFU-E were counted as described above. For statistical analysis, the Student's 
t test was used. 
Liver Cell Cultures.  For studies of the effects  of steroids on ALA-S synthesis and porphyrin 
formation  in  liver cells,  serum-free cultures  of chick embryo liver cells  were prepared,  and 
determinations of ALA-S activity and porphyrin concentrations were carried out as described 
previously (19). 
Results 
Benzidine staining, using acidic solutions for the detection of hemoglobinized cells, 
may  also  give  rise  to  positive  staining  with  granulocyte-macrophage  colonies  that 
contain  peroxidases.  To avoid  false-positive  results,  red or reddish  colonies without 
staining were counted as reported previously (20, 21). Morphological identification of 
erythroblasts  was  made  after  Wright-Giemsa  staining  of smeared  cell  preparations 
prepared  by a  Cytocentrifuge (Shandon Southern  Instruments Inc., Sewickley, Pa.). 
Numbers of BFU-E and CFU-E increased in a  dose-dependent  manner as a  function 
of erythropoietin  concentrations  as well  as a  function of the input  cell  number.  No 
erythroid colonies  (CFU-E)  or erythroid bursts  (BFU-E)  were observed with steroid 
treatment  alone in the absence of erythropoietin  (data not shown). 
Table  1 shows the effects of the continued presence of each steroid throughout the 
entire  incubation  period on erythroid colony formation. Out of six pairs of steroids 
tested, four of the pairs (A-D) were C19 compounds and two (E, F) were C21 steroids. 
The steroids alone were not stimulatory on erythroid colony formation in the absence 
of erythropoietin.  However,  when  cultures  contained  0.1  U  of erythropoietin/ml, 
certain steroids enhanced the growth of both CFU-E and BFU-E. In this respect, 5fl- 
steroids were nearly always more effective than their 5a-epimers.  Specifically, all four 
androstanes  (A-D) and one (F)  out of two pregnanes  (E, F)  having the 5fl-structure, 
were  more  effective  in  increasing  CFU-E  significantly  as  compared  with  control 
cultures which were treated with erythropoietin  alone; both 5a-pregnane derivatives 
(E, F)  also stimulated  CFU-E formation and one of these compounds  (E)  was more 
active  than  the  5fl-epimer.  No  C19  5a-steroid  significantly  increased  BFU-E  and 
CFU-E  formation.  All  5fl-steroids  increased  BFU-E  significantly.  The  extent  of 
stimulation  of erythroid colonies by the active steroids ranged from 200 to 260% for 
CFU-E and from  140 to 200% for BFU-E above controls. 
We have previously reported that the activity of URO-S, a cytosolic enzyme in the 
heine biosynthetic pathway, is an early and sensitive marker for erythroid differentia- 
tion  both  in  mouse  Friend  erythroleukemia  cells  (23)  and  in  normal  human  bone 
marrow cultures  (24).  URO-S activity determined  in cells  harvested  on day  7 after AKIO URABE,  SHIGERU SASSA, AND ATTALLAH KAPPAS 
TABLE  I 
Effect of Steroids on E~ythroid-Colony  Formation 
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Pair  Steroid  CFU-E*  BFU-E* 
Control  (propylene glycol)  30.0 3= 3.0  23.0 =t:  1.0 
A  5a-Androstan-3a-ol-17-one  39.5 =t= 5.5  26.5 =t: 0.5 
5fl-Androstan-3a-ol-17-one  73.5 =l= 3.5:~  38.0 :t= 3.0:~ 
B  5a-Androstan-3fl-ol-17-one  38.0 =l= 8.0  29.5 =1= 2.5 
5fl-Androstan-3fl-ol-17-one  61.0 =l= 6.0:~  31.5 -1- 0.5~ 
C  5a-Androstan-17-one  44.0 +  3.0  25.5 =1=  1.5 
5fl-Androstan-17-one  79.0 +  8.0:~  45.5 3= 0.5:~ 
D  5a-Androstan-3a, llfl-diol-17-one  38.5 :t= 7.5  23.5 3= 6.5 
5fl-Androstan-3a, l lfl-diol-17-one  73.0 3= 6.0:1:  37.5 +  0.5:[: 
E  5a-Pregnane-3fl,17a-diol-20-one  67.5 3= 0.5:1:  26.5 :l: 0.5 
5fl-Pregnane-3fl,17a-diol-20-one  50.0 +  4.0  35.5 +  0.5:~ 
F  5a-Pregnan-l 1-one  58.0 +  4.0:1:  29.0 +  4.0 
5fl-Pregnan-1 l-one  63.0 +  6.0¢  37.5 +  0.5:[: 
All cultures contained 0. I U erythropoietin/ml. Steroids were added to a concen- 
tration of l0  -7 M. No erythroid colonies were observed when erythropoietin was not 
added. 
* CFU-E and BFU-E are expressed as mean numbers of erythroid colonies +  SEM 
per 2 ×  l05 input nucleated cells on day 7 (CFU-E) and on day 14 (BFU-E). 
:~ P < 0.05, significantly different from the control value. 
incubation  with  steroids  and  erythropoietin exhibited a  general  parallelism to  the 
activity  ratio  of 5fl-  and  5a-compounds  in  inducing  CFU-E  formation  (data  not 
shown). 
Preincubation of cells with 5a- and 5fl-steroids (seven pairs)  for 48 h, followed by 
incubation with erythropoietin, did not  reveal any effect of either 5a- or 5fl-steroids 
on the growth of CFU-E  (Table II). On the other hand,  in five of the seven pairs of 
compounds,  the 5fl-epimer significantly enhanced  the growth of BFU-E  (Table II). 
Dihydroxycoprostane and trihydroxycoprostane, which are 5fl-neutral sterols and 
normal intermediates in bile acid synthesis from cholesterol, also displayed significant 
stimulation of BFU-E, but not of CFU-E formation. These steroids have been shown 
to be porphyrinogenic in avian liver cells (25). 
Table III depicts the effects of the administration of a  pair of 5a- and 5fl-steroids 
after initiation of cultures.  The  5a-compound  had  no stimulatory effect on  BFU-E 
and  CFU-E  formation  irrespective of the time of addition to the cultures.  The  5fl- 
steroid enhanced the colony growth of CFU-E only when added simultaneously with 
the  establishment  of the  cultures;  this  derivative also enhanced  BFU-E  formation 
when added within 2 d  after the initiation of the cultures, but did not further affect 
erythroid colony development when added thereafter. These cultures contained 0.25 
U/ml  erythropoietin throughout  the incubation periods. 
The same steroid solutions in propylene glycol were tested for induction of porphy- 
rins  (13  or  16  #M)  in  serum-free  cultures  of chick  embryo  liver  cells  using our 
technique described previously (19)  and induction of ALA-S (2.5 or 10/.tmol/egg) in 1318  STEROID  METABOLITE  EFFECT  ON  HUMAN  ERYTHROID  COLONY 
TABL~  II 
Effect of Premcubation with Steroids on E~ythroid-Colony Formation 
Pair  Steroid  CFU-E*  BFU-E* 
A 
D 
G 
Control (propylene glycol)  221  ±  2  37.5  ±  2.9 
5a-Androstan-3a-ol-17-one  187  ±  1  44.5  ±  4.2 
5/~-Androstan-3a-ol-17-one  200  ±  3  59.8  ±  2.1:1: 
5a-Androstan-3/~-ol-17-one  223  ±  1  42.0  ±  3.0 
5~-Androstan-3~-ol-17-one  195  ±  16  61.5  ±  6.6:~ 
5a-Androstan-17-one  162  ±  13  41.8  ±  2.2 
5/~-Androstan-17-one  231  ±  11  28.7  ±  5.2 
5ot-Androstan-3a, l l/~-diol-17-one  187  ±  9  35.0  ±  1.0 
5~-Androstan-3~,ll~-diol-17-one  180  ±  1  54.3  ±  3.1:~ 
5a-Pregnane-3/~,17a-diol-20-one  167  ±  2  53.3  ±  6.4 
5/~-Pregnane-3l~,17ot-diol-20-one  185  ±  10  36.8  ±  6.1 
5a-Pregnan-ll-one  169  ±  13  37.5  ±  1.0 
5B-Pregnan-ll-one  174  ±  11  61.8  ±  4.0:~ 
5a-Pregnan-3a,17a-diol-20-one  201  +  2  46.8  ±  3.4 
5~-Pregnan-3a,17a-diol-20-one  185  ±  2  62.8  +  2.6z~ 
3a,7a-dihydroxycoprostane  204  ±  11  60.5  +  6.0:~ 
3a,7a,12ot-trihydroxycoprostane  228  ±  14  50.8  +  2.9:1: 
Normal human bone marrow cells were preincubated with steroids at a concentra- 
tion of 10  -7 M  for 48 h. After washing three times, cells were incubated in semi-solid 
medium supplemented with methylcellulose in the presence of 0.5 U  of erythropoi- 
etin/ml. CFU-E and BFU-E were enumerated as described in the text. 
* CFU-E and BFU-E are expressed as mean numbers of erythroid colonies  ±  SEM 
per 2  ×  105 input nucleated cells on day 7 (CFU-E) and on day 14 (BFU-E). 
:~ P<  0.05, significantly greater than the control value. 
TABLE III 
Effect of Delayed Addition  of Steroids on E~ythroid-Colony Formation 
Steroid  Day of  CFU-E*  BFU-E* 
administration 
Control (propylene glycol)  0  85.0  +  3.0  30.2  +  2.0 
i  77.0  +  1.0  34.5  ±  0.5 
5a-Androstan-3a-I l/~-diol-17-one  67.5  ±  7.5  37.0  ±  3.0 
77.0  ±  11.0  31.5  +  0.5 
i  125.0  +  3.0:1:  40.5:1:  0.5:1: 
5/~-Androstan-3a-ll/~-diol-17-one  82.0  ±  1.0  42.0  ±  1.0~ 
66.0  ±  4.0  37.0  ±  5.0 
Steroids were added at a concentration of 10  -7 M  on days as indicated in the table. 
All cultures contained 0.25 U  of erythropoietin/ml. 
* CFU-E and BFU-E are expressed as mean numbers of erythroid colonies ±  SEM 
1: P <  0.05, significantly greater than the control value. AKIO URABE, SHIGERU  SASSA,  AND  ATTALLAH  KAPPAS  1319 
TABLE  IV 
Relative Activity of 5a- and 5fl-Steroids on the Induction of ALA-Synthase and Porphyrins in Chick 
Embryo Liver 
Pairs  Steroid structures 
5fl/5a inducing ratios 
Human bone marrow  Chick embryo liver 
CFU-E  BFU-E  BFU-E 
(continuous incu-  (preincuba-  ALA-Syn-  Protopor- 
bation with ste-  tion with  thase*  phyrin:~ 
roid)  steroid) 
A  (5fl-  and  5a)-Androstan-3a-ol-17-  1.9  1.4  1.3  1.3  1.4 
one (etiocholanolone and andros- 
terone) 
B  (5fl-  and  5a)-Androstan-3fl-ol-17-  1.6  1.1  1.5  1.8  2.1 
one 
C  (5fl- and 5a)-Androstan-17-one  1.8  1.8  0.7  ND  4.7 
D  (5fl-  and  5a)-Androstan-3a,llfl-  1.9  1.6  1.6  1.7  0.7 
diol- 17-one 
E  (5,8- and 5a)-Pregnane-3fl,17a-diol-  0.7  1.3  0.7  4.3  4.6 
20-one 
F  (5fl- and 5a)-Pregnan-  1  l-one  1.1  1.3  1.6  2.2  ND 
G  (5fi-  and  5a)-Pregnan-3a-  17a-diol-  ND  ND  1.3  ND  ND 
20-one 
ND, not determined. 
* ALA-synthase activity was determined in livers from chick embryo treated for 9 h with 2.5-10 #mol of 
steroid/egg as described previously  (41). 
:~ Porphyrin formation was determined in the serum-free cultures of chick embryo liver cells as described 
previously  (19). Concent  rations of steroids used were 13-16 #M. 
§ Only the pair D showed an apparent lesser activity of 5fl- than 5a-compounds (the ratio:0.7)  on porphyrin 
formation. However, when 5 mM CaMgEDTA was supplemented together with the steroid to prevent 
the loss of protoporphyrin from the ferrochelatase step, the same pair of compounds displayed a 5fl/5a- 
inducing ratio of 6,3. 
the chick embryo liver in  ovo. 2 These steroid concentrations were found to be optimal 
for induction in the respective model systems. As indicated in Table IV, 5~-steroids 
were generally more potent  than  5a-steroids with  respect  to both the induction of 
porphyrinogenesis and the stimulation of ALA-S formation. 
Discussion 
The results of this study demonstrate that certain 5a- and 5~-steroid metabolites 
are effective in enhancing the growth, in cultured human bone marrow cells, of both 
BFU-E and CFU-E in the presence of a  low dose of erythropoietin. In this respect, 
five  of six  steroids  of the  5~-configuration  tested,  were  effective  in  significantly 
increasing CFU-E (Table I) and all 5fl-steroids increased BFU-E significantly (Table 
I).  In contrast, only two 5a-steroids stimulated  the  growth  of CFU-E,  and  no 5a- 
steroids stimulated  the  growth  of BFU-E.  No  steroids demonstrated  an  inhibitory 
effect on erythroid colony formation. 
These data are consistent with earlier observations which showed a greater potency 
2 Sassa, S., 'H. L, Bradlow, and A. Kappas. 1979. Steroid induction of 8-aminolevulinic  acid synthase 
and porphyrins in liver. Structure-activity studies and the permissive effects of hormones on the induction 
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of 5/~-steroids  as  compared  with  5a-steroids  in  the  induction  of porphyrin-heme 
biosynthesis in avian embryonic liver (1-3), as well as the stimulation oferythropoiesis 
in  developing avian  blastoderm  (4).  This  structure-activity relationship  of steroid 
metabolites was subsequently shown to extend to heme and globin synthesis in human 
bone marrow cells in suspension cultures (9,  10). More potent actions of 5/~-steroids, 
as  compared  with  5a-steroids,  have  also  been  shown  by  ~gFe incorporation  into 
erythrocytes in  exhypoxic polycythemic mice  (6,  7), ALA-S induction  in the chick 
blastoderm (26), and by in vitro growth stimulation of CFU-E using rat bone marrow 
cultures (15). 
Extensive studies on structure-inducibility relationships of these steroids on CFU-E 
formation by Singer et al. (15) clearly indicated that most 5/~-metabolites are potent 
inducers  of erythropoiesis in  rodent  bone  marrow.  The  summary  of 5/~- and  5a- 
inducing ratios shown  in Table IV confirms, in  the  tissue  types indicated  (human 
bone marrow and avian liver), the generally more potent inducing activity of the 5/~- 
steroid structure. A common phenomenon occurring in these systems after treatment 
with 5/~-steroids is the induction of ALA-S with a subsequent increase in porphyrins 
or heme (1-3, 27).  Induction of this rate-limiting enzyme in heine synthesis has, in 
fact, been  suggested  as  a  key metabolic event in  the  mechanism  by which  steroid 
metabolites exert their stimulatory effects on heine synthesis (9, 27). 
Because steroid metabolites may exhibit equal or greater biological potency in these 
systems  than  their  precursor hormones,  the  role of hormone biotransformation  to 
active derivatives in these systems remains a matter for further study; the phenomenon 
of metabolic conversion of parent chemical structures to biologically active derivatives 
by microsomal and  other cellular enzymes is  common and  is  known  to extend to 
hormones. It should be noted that on a  molar basis steroid metabolites are at least 
100-fold more active in  stimulating  erythroid colony formation from human  bone 
marrow cells than they are in inducing ALA-S or porphyrin formation in avian liver 
cells. This sensitivity of bone marrow cells to steroids including glucocorticoids extends 
to other species such as rats (15)  rabbits  (28), and man  (29), suggesting an intrinsic 
biological characteristic of these cell types as compared with hepatic cells. Stimulation 
of BFU-E formation by the coprostane compounds is of particular interest because 
these neutral sterol metabolites of cholesterol are produced in large amounts in man. 
The structure-inducibility relationship of these steroid metabolites to BFU-E, the 
most primitive erythroid progenitor cells, has not been extensively examined, except 
for the single pair of metabolites studied by Fisher et al.  (28).  These authors found, 
utilizing rabbit  bone marrow cultures, that  both the parent  hormone, testosterone, 
and  its  metabolites,  5a-  and  5/~-dihydrotesterone  (DHT)  stimulated  the  in  vitro 
growth of BFU-E in the presence of erythropoietin but that 5~-DHT was significantly 
more potent  than  the  5a  derivative of the  hormone (5a-DHT)  in  this action  (28). 
When animals were pretreated with  these steroids, both testosterone and  5/~-DHT, 
but  not  5a-DHT, gave rise to increased erythroid-colony formation in culture (28). 
These  in  vivo  findings  in  rabbits  contrast  with  earlier  studies  carried  out  by  a 
cooperative group study utilizing polycythemic mice as a  model test system (30).  In 
any  event,  it  appears  from  recent  work  that  5/~-DHT  is  clearly more effective in 
stimulating erythroid differentiation in vivo in the rabbit than is 5a-DHT, and that 
this  relative potency of 5/~-DHT over 5a-DHT extends to cultured erythroid cells 
from this species (28). AKIO URABE, SHIGERU  SASSA, AND ATTALLAH KAPPAS  1321 
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FIG.  l.  Hypothetical scheme  of sites of action of steroids and erythropoietin  on erythroid progenitor 
cells. The site of erythropoietin (Ep) action has been considered to appear at the developmental 
stage between BFU-E and CFU-E. In contrast, the steroid action appears to occur at much earlier 
developmental stage of erythroid progenitors cells than Ep-sensitive  precursors. It should be noted, 
however, that  the steroid action on erythroid colony formation requires continuous presence or 
subsequent addition of erythropoietin. CFU-S, muhipotential stem cell; Pro E, proerythroblast; 
Baso E, basophilic erythroblast; Poly E, polychromatophilic  erythroblast; Ortho E, orthochroma- 
tophilic erythroblast; Ret, reticulocyte; RBC, erythrocytes. 
Our results in this study represent the first demonstration in normal human marrow 
cell cultures that certain C 19 and C21  metabolites stimulate erythroid colony growth 
and that 5/~-metabolites are generally more potent in this action than their correspond- 
ing  epimers.  In  our  experiments,  BFU-E  formation  was  enhanced  by  short-term 
preincubation with or the continued presence of 5fi-steroids in the cultures, whereas 
CFU-E  formation was not  enhanced  by a  preincubation  with steroids;  rather their 
continued presence throughout the incubation period was required. This suggests that 
the growth of erythroid colonies by day 7 may be, in part, a result of enhanced colony 
formation derived  from steroid-responsive erythroid  progenitor cells which  may lie 
between  BFU-E  and  CFU-E.  In  fact, human  erythroid cells appear to represent  a 
continuous and wide spectrum of erythropoietic precursors (21,  31). URO-S activity 
in cells which were harvested after 7 d of incubation, showed that 5fl-steroids were, in 
general,  more  stimulatory  of this  enzyme  activity  than  5a-compounds  (data  not 
shown). This enhanced URO-S activity most likely reflects increased proliferation of 
erythroid  cells  in  the  cultures;  however,  in  lymphocytes induction  of the  enzyme 
appears to take place after mitogen-stimulation (32). 
The cellular response to erythropoietin is considered to appear in the developmental 
stage  between  BFU-E  and  CFU-E  (33)  (Fig.  1).  In  this  respect,  our  results,  after 
preincubation of human bone marrow cells with steroids, are interesting in that 5/~- 
steroids increased only BFU-E formation but not CFU-E. This suggests that the effect 
of 5/~-steroids on erythroid  progenitors  is  directed  towards  an even earlier stage of 
erythroid differentiation than  that of erythropoietin-responsive cells  (Fig.  1).  Singer 
and  Adamson  (16),  using  velocity sedimentation  and  cell-cycle kinetic  techniques, 
reported  that  the  etiocholanolone-responsive  erythroid  progenitors  showed  many 
similarities to those of BFU-E type and were different from erythropoietin-dependent 
CFU-E. Because the 3H-thymidine suicide rate of etiocholanolone-responsive cells was 
substantially lower than that of erythropoietin-responsive cells, they concluded  that 
this  5/~-steroid  probably acts on  a  separate,  perhaps  more primitive population  of 
marrow cells  (16).  It is also known  that  an antibody preparation  to erythropoietin 
abolishes the erythropoietic effect of testosterone in in vivo exhypoxic polycythemic 
mice (7, 34) but not that of 5fl-steroids (7). Our results in Table III further substantiate 
the idea that 5fi-steroids act principally on early erythroid progenitor cells; as noted, 
for example in Table III the 5/~-derivative enhanced  the growth of CFU-E colonies 
only when it was added on day 0, and increased the formation of BFU-E only when 1322  STEROID  METABOLITE  EFFECT ON  HUMAN ERYTHROID  COLONY 
it was added on day 0 or day 2, but not thereafter. These findings suggest that  the 
functional responses of early erythroid progenitor cells to steroids may be rapidly lost 
in cultures after 48 h  and that delayed addition of steroids to the cultured cells has 
little effect on the maturation of erythroid percursors. 
Hormonal  effects on  erythropoiesis have  been  recognized  for a  long  time  (35). 
Differences  of erythrocyte count,  hemoglobin  concentration,  and  hematocrit  are 
known to exist between men and women and are considered to be a result of the effect 
of gonadal hormones (36). Androgen therapy for anemia in patients with a variety of 
blood disorders  (37,  38),  including  aplastic  anemia  (39), was  initiated  almost  two 
decades ago but still presents troublesome problems of masculinization and growth 
side-effects in women and children. Those steroid metabolites known to lack andro- 
genicity  (i.e.  5fl-derivatives)  may  prove useful  in  treatment  of certain  intractable 
anemias  of man,  but  extensive  clinical  studies  of this  possibility  have  not  been 
undertaken to our knowledge. Recently, Besa et al. (17) reported that one 5fl-steroid, 
etiocholanolone, could stimulate erythropoiesis in some patients with aplastic anemia. 
It  should  be  noted,  however,  that  certain  5fl-steroids  (including  etiocholanolone) 
which are known to induce heme synthesis also have potent inflammatory and fever- 
producing activity in man  (40); certain other 5fl-derivatives which can activate the 
heme pathway do not have these properties. Thus, a  careful selection of 5fl-steroids 
with appropriate consideration  of  their structural and biological properties is necessary 
for human studies. 
It should be emphasized that the steroids utilized in this study are derived from the 
in vivo biotransformation of endogenous hormones. The localization of the develop- 
mental stage at which these steroids act on erythroid progenitor cells is of considerable 
fundamental interest and may provide useful information regarding the mechanisms 
and  sites  of steroid  actions  on  cell  growth.  It  may also  facilitate the  use of these 
physiologically derived compounds  for the stimulation  of erythropoiesis in  certain 
forms of bone marrow failure in man as we have suggested earlier (1, 4). 
Summary 
Certain  C19  and  C21  steroid metabolites,  when  incubated  with  normal  human 
bone  marrow  cells  in  culture,  increased  the  number  of erythroid  colonies  in  the 
presence of erythropoietin. Among a  number of pairs of C5 epimeric steroids tested, 
most 5fl (A:B cis) steroids stimulated the growth of both early erythroid progenitor 
cells (BFU-E) and late erythroid progenitor cells (CFU-E), whereas only a few 5a-(A: 
B tram) steroids stimulated the growth of CFU-E. No 5a-compounds of six pairs of 
steroids studied  were  found to stimulate  BFU-E  formation. This structure-activity 
relationship conforms with that previously observed in studies of steroid induction of 
ALA-synthase in avian embryo liver cells and hemoglobin synthesis in the cultured 
avian blastoderm. 
When  human  bone  marrow  cells  were  preincubated  with  the  steroids  for  2  d, 
followed by incubation with erythropoietin, only the 5fl-compounds stimulated  the 
growth  of BFU-E.  Similarly, when  addition  of steroids was  delayed in  relation  to 
erythropoietin  in  the  culture,  only  the  5/~-derivative  of  a  pair  of  C5  epimeric 
compounds  displayed  an  enhancing  effect on  the  growth  of BFU-E.  This  effect 
required that the steroid addition be made no later than 48 h  after initiation of the 
culture. These data demonstrate that certain natural steroid metabolites significantly AKIO URABE,  SHIGERU SASSA, AND ATTALLAH KAPPAS  1323 
stimulate  erythropoiesis  in  normal  human  bone  marrow cells  in culture.  They also 
indicate  that  5~8-compounds are  more stimulatory  than  their  5~x-epimers,  and  they 
suggest that these 5,8-steroids act preferentially on very primitive erythroid progenitor 
cells, probably on BFU-E. 
We are indebted to Dr. H. L. Bradlow, Laboratory of Steroid Biochemistry, The Rockefeller 
University, for the preparation and purification of steroids used in this study. A. U. is indebted 
to  Doctors  M.  A.  S.  Moore  and  M. J.  Murphy, Jr.,  Sloan-Kettering  Institute  for Cancer 
Research, for their generous support. 
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